Wealth Quarterback LLC Ligand Pharmaceuticals Inc Transaction History

Wealth Quarterback LLC

  • $212 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$74.52 - $117.06 $9,165 - $14,398
-123 Closed
0 $0
Q2 2021

Aug 11, 2021
BUY
$113.03 - $155.64 $13,902 - $19,143
123 New
123 $17,000
Q2 2020

Aug 17, 2020
SELL
$68.28 - $123.65 $9,081 - $16,445
-133 Closed
0 $0
Q4 2019

Feb 27, 2020
BUY
$96.94 - $113.59 $12,893 - $15,107
133 New
133 $13,000

Others Institutions Holding LGND

# of Institutions
277
Shares Held
18.5M
Call Options Held
30.8K
Put Options Held
5.2K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.83B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Wealth Quarterback LLC Portfolio

Follow Wealth Quarterback LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Quarterback LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Quarterback LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email